Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05933304 · ClinicalTrials.gov registry record
A Study of the Effectiveness of Moderna COVID-19 Vaccine
A clinical trial, sponsored by ModernaTX.
- Completed
- Registry status
- 927,004
- Enrollment target
NCT05933304 is a clinical trial that has completed, run by ModernaTX. The registered enrollment target is 927,004 participants.
The verdict
NCT05933304 has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- 927,004 participants
- Enrollment target
Study Summary
This is an observational cohort study to evaluate real-world vaccine effectiveness and durability of Moderna COVID-19 vaccine among a diverse population at Kaiser Permanente Southern California (KPSC). The primary objective of this study is to evaluate the vaccine effectiveness (VE) of receipt of Moderna COVID-19 vaccine in preventing SARS-CoV-2 infection and severe COVID-19 disease. SARS-CoV-2 infection will be defined as a positive antigen test result as well as a positive molecular diagnostic test among symptomatic or asymptomatic participants or a COVID-19 diagnosis code. Severe COVID-19 disease will be defined as COVID-19 hospitalization or mortality.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 927,004 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2023-11-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05933304
The ClinicalTrials.gov registry entry for NCT05933304 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 927,004 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05933304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05933304 about?
NCT05933304 is a clinical study titled "A Study of the Effectiveness of Moderna COVID-19 Vaccine". This is an observational cohort study to evaluate real-world vaccine effectiveness and durability of Moderna COVID-19 vaccine among a diverse population at Kaiser Permanente Southern California (KPSC). The primary objective of this study is to evaluate the vaccine effectiveness (VE) of receipt of M...
What is the current status of trial NCT05933304?
This trial is currently completed. The enrollment target is 927,004 participants. The study started on 2020-12-18. Estimated completion is 2023-11-17.
Who is sponsoring clinical trial NCT05933304?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.